Liposomal magnetofection
- PMID: 20072903
- DOI: 10.1007/978-1-60327-360-2_34
Liposomal magnetofection
Abstract
In a magnetofection procedure, self-assembling complexes of enhancers like cationic lipids with plasmid DNA or small interfering RNA (siRNA) are associated with magnetic nanoparticles and are then concentrated at the surface of cultured cells by applying a permanent inhomogeneous magnetic field. This process results in a considerable improvement in transfection efficiency compared to transfection carried out with nonmagnetic gene vectors. This article describes how to synthesize magnetic nanoparticles suitable for nucleic acid delivery by liposomal magnetofection and how to test the plasmid DNA and siRNA association with the magnetic components of the transfection complex. Protocols are provided for preparing magnetic lipoplexes, performing magnetofection in adherent and suspension cells, estimating the association/internalization of vectors with cells, performing reporter gene analysis, and assessing cell viability. The methods described here can be used to screen magnetic nanoparticles and formulations for the delivery of nucleic acids by liposomal magnetofection in any cell type.
Similar articles
-
siRNA delivery by magnetofection.Curr Opin Mol Ther. 2008 Oct;10(5):493-505. Curr Opin Mol Ther. 2008. PMID: 18830925 Review.
-
Recent advances in magnetofection and its potential to deliver siRNAs in vitro.Methods Mol Biol. 2009;487:111-46. doi: 10.1007/978-1-60327-547-7_6. Methods Mol Biol. 2009. PMID: 19301645
-
Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.Methods Mol Biol. 2010;605:461-72. doi: 10.1007/978-1-60327-360-2_32. Methods Mol Biol. 2010. PMID: 20072901
-
Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide.Biomaterials. 2010 Feb;31(4):769-78. doi: 10.1016/j.biomaterials.2009.09.085. Epub 2009 Oct 9. Biomaterials. 2010. PMID: 19819012
-
siRNA and DNA transfer to cultured cells.Methods Mol Biol. 2009;480:31-52. doi: 10.1007/978-1-59745-429-2_3. Methods Mol Biol. 2009. PMID: 19085120 Review.
Cited by
-
Optimization of magnetic nanoparticle-assisted lentiviral gene transfer.Pharm Res. 2012 May;29(5):1255-69. doi: 10.1007/s11095-011-0660-x. Epub 2012 Jan 25. Pharm Res. 2012. PMID: 22274554
-
Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.Adv Drug Deliv Rev. 2011 Nov;63(14-15):1300-31. doi: 10.1016/j.addr.2011.08.002. Epub 2011 Aug 26. Adv Drug Deliv Rev. 2011. PMID: 21893135 Free PMC article. Review.
-
In vivo magnetofection: a novel approach for targeted topical delivery of nucleic acids for rectoanal motility disorders.Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G109-G118. doi: 10.1152/ajpgi.00233.2017. Epub 2017 Oct 19. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29051187 Free PMC article.
-
Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.Pharm Res. 2012 May;29(5):1344-65. doi: 10.1007/s11095-011-0661-9. Epub 2012 Jan 6. Pharm Res. 2012. PMID: 22222384
-
HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.Mol Ther. 2017 Jul 5;25(7):1616-1627. doi: 10.1016/j.ymthe.2017.04.007. Epub 2017 Apr 20. Mol Ther. 2017. PMID: 28434868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources